RFCA
ALXN

R&F Capital Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

R&F Capital Advisors’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q1 		$710K Buy
5,857
+3,061
+109% +$371K 0.18% 163
2016
Q4 		$342K Buy
+2,796
New +$342K 0.12% 272